These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Chronic HB virus hepatitis in children. A study of 29 cases]. Maggiore G; Marzani D; De Giacomo C; Sessa F; Civardi G; Scotta MS Sem Hop; 1984 May; 60(19):1349-52. PubMed ID: 6326326 [TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic active hepatitis--present state. The pros and cons of immunosuppressive therapy. Thaler H Hepatogastroenterology; 1984 Feb; 31(1):6-11. PubMed ID: 6698488 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. A report from a study group for CAH of the Italian Association for the study of the liver. Giusti G; Piccinino F; Galanti B; Sagnelli E; Ruggiero G; Gallo C Hepatogastroenterology; 1984 Feb; 31(1):24-9. PubMed ID: 6698485 [TBL] [Abstract][Full Text] [Related]
12. [Progress in the treatment of chronic active liver diseases]. Buligescu L; Spanache S Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(5):413-27. PubMed ID: 2434980 [No Abstract] [Full Text] [Related]
13. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2. Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327 [TBL] [Abstract][Full Text] [Related]
14. Changes in results of Gallium-67-citrate scanning after interferon therapy for chronic hepatitis C. Shiomi S; Kuroki T; Yokogawa T; Takeda T; Nishiguchi S; Nakajima S; Tanaka T; Okamura T; Ochi H J Nucl Med; 1997 Feb; 38(2):216-9. PubMed ID: 9025739 [TBL] [Abstract][Full Text] [Related]
15. Prophylaxis and therapy of HBsAg positive hepatitis. Weimar W; Schellekens H Biomedicine; 1979 Jul; 30(3):135-8. PubMed ID: 486686 [TBL] [Abstract][Full Text] [Related]
16. [The onset of psychiatric disorders and Wilson's disease]. Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784 [TBL] [Abstract][Full Text] [Related]
17. The spectrum of chronic active liver disease. Kaplan MM Hosp Pract (Off Ed); 1983 Oct; 18(10):67-76. PubMed ID: 6413379 [TBL] [Abstract][Full Text] [Related]
18. Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B. Stancek D; Hajnická V; Blaskovicová H; Sudová J; Laktis K; Janota S; Jezek P Acta Virol; 1990 Sep; 34(5):457-66. PubMed ID: 1981456 [TBL] [Abstract][Full Text] [Related]